The Role of Osimertinib in Treatment Naive Epidermal Growth Factor Receptor-Mutated Stage IIIB or IV Non-Small-Cell Lung Cancer Patients

被引:1
作者
Uprety, Dipesh [1 ]
Bista, Amir [2 ]
Vallatharasu, Yazhini [2 ]
Arjyal, Lubina [2 ]
机构
[1] Gundersen Hlth Syst, Dept Hematol & Med Oncol, 1900 South Ave,Mail Stop EB2-001, La Crosse, WI 54601 USA
[2] Gundersen Hlth Syst, Gundersen Lutheran Med Ctr, La Crosse, WI 54601 USA
关键词
EGFR; NSCLC; osimertinib; QUALITY-OF-LIFE; 1ST-LINE TREATMENT; OPEN-LABEL; PHASE-III; EGFR TKI; GEFITINIB; SURVIVAL; AZD9291; CHEMOTHERAPY; AFATINIB;
D O I
10.1177/1179554918779585
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页数:2
相关论文
共 17 条
[1]  
[Anonymous], J CLIN ONCOL S
[2]   AZD9291, an Irreversible EGFR TKI, Overcomes T790M-Mediated Resistance to EGFR Inhibitors in Lung Cancer [J].
Cross, Darren A. E. ;
Ashton, Susan E. ;
Ghiorghiu, Serban ;
Eberlein, Cath ;
Nebhan, Caroline A. ;
Spitzler, Paula J. ;
Orme, Jonathon P. ;
Finlay, M. Raymond V. ;
Ward, Richard A. ;
Mellor, Martine J. ;
Hughes, Gareth ;
Rahi, Amar ;
Jacobs, Vivien N. ;
Brewer, Monica Red ;
Ichihara, Eiki ;
Sun, Jing ;
Jin, Hailing ;
Ballard, Peter ;
Al-Kadhimi, Katherine ;
Rowlinson, Rachel ;
Klinowska, Teresa ;
Richmond, Graham H. P. ;
Cantarini, Mireille ;
Kim, Dong-Wan ;
Ranson, Malcolm R. ;
Pao, William .
CANCER DISCOVERY, 2014, 4 (09) :1046-1061
[3]   Overall survival in non-small cell lung cancer-what is clinically meaningful? [J].
Fenchel, Klaus ;
Sellmann, Ludger ;
Dempke, Wolfram C. M. .
TRANSLATIONAL LUNG CANCER RESEARCH, 2016, 5 (01) :115-119
[4]   EGFR testing in lung cancer is ready for prime time [J].
Hirsch, Fred R. ;
Bunn, Paul A., Jr. .
LANCET ONCOLOGY, 2009, 10 (05) :432-433
[5]   AZD9291 in EGFR Inhibitor-Resistant Non-Small-Cell Lung Cancer [J].
Jaenne, Pasi A. ;
Yang, James Chih-Hsin ;
Kim, Dong-Wan ;
Planchard, David ;
Ohe, Yuichiro ;
Ramalingam, Suresh S. ;
Ahn, Myung-Ju ;
Kim, Sang-We ;
Su, Wu-Chou ;
Horn, Leora ;
Haggstrom, Daniel ;
Felip, Enriqueta ;
Kim, Joo-Hang ;
Frewer, Paul ;
Cantarini, Mireille ;
Brown, Kathryn H. ;
Dickinson, Paul A. ;
Ghiorghiu, Serban ;
Ranson, Malcolm .
NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (18) :1689-1699
[6]   Gefitinib or Chemotherapy for Non-Small-Cell Lung Cancer with Mutated EGFR. [J].
Maemondo, Makoto ;
Inoue, Akira ;
Kobayashi, Kunihiko ;
Sugawara, Shunichi ;
Oizumi, Satoshi ;
Isobe, Hiroshi ;
Gemma, Akihiko ;
Harada, Masao ;
Yoshizawa, Hirohisa ;
Kinoshita, Ichiro ;
Fujita, Yuka ;
Okinaga, Shoji ;
Hirano, Haruto ;
Yoshimori, Kozo ;
Harada, Toshiyuki ;
Ogura, Takashi ;
Ando, Masahiro ;
Miyazawa, Hitoshi ;
Tanaka, Tomoaki ;
Saijo, Yasuo ;
Hagiwara, Koichi ;
Morita, Satoshi ;
Nukiwa, Toshihiro .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (25) :2380-2388
[7]   Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial [J].
Mitsudomi, Tetsuya ;
Morita, Satoshi ;
Yatabe, Yasushi ;
Negoro, Shunichi ;
Okamoto, Isamu ;
Tsurutani, Junji ;
Seto, Takashi ;
Satouchi, Miyako ;
Tada, Hirohito ;
Hirashima, Tomonori ;
Asami, Kazuhiro ;
Katakami, Nobuyuki ;
Takada, Minoru ;
Yoshioka, Hiroshige ;
Shibata, Kazuhiko ;
Kudoh, Shinzoh ;
Shimizu, Eiji ;
Saito, Hiroshi ;
Toyooka, Shinichi ;
Nakagawa, Kazuhiko ;
Fukuoka, Masahiro .
LANCET ONCOLOGY, 2010, 11 (02) :121-128
[8]   Osimertinib or Platinum-Pemetrexed in EGFR T790M-Positive Lung Cancer [J].
Mok, T. S. ;
Wu, Y. -L. ;
Ahn, M. -J. ;
Garassino, M. C. ;
Kim, H. R. ;
Ramalingam, S. S. ;
Shepherd, F. A. ;
He, Y. ;
Akamatsu, H. ;
Theelen, W. S. M. E. ;
Lee, C. K. ;
Sebastian, M. ;
Templeton, A. ;
Mann, H. ;
Marotti, M. ;
Ghiorghiu, S. ;
Papadimitrakopoulou, V. A. .
NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (07) :629-640
[9]   Afatinib versus gefitinib in patients with EGFR mutation-positive advanced non-small-cell lung cancer: overall survival data from the phase IIb LUX-Lung 7 trial [J].
Paz-Ares, L. ;
Tan, E. -H. ;
O'Byrne, K. ;
Zhang, L. ;
Hirsh, V. ;
Boyer, M. ;
Yang, J. C. -H. ;
Mok, T. ;
Lee, K. H. ;
Lu, S. ;
Shi, Y. ;
Lee, D. H. ;
Laskin, J. ;
Kim, D. -W. ;
Laurie, S. A. ;
Kolbeck, K. ;
Fan, J. ;
Dodd, N. ;
Marten, A. ;
Park, K. .
ANNALS OF ONCOLOGY, 2017, 28 (02) :270-277
[10]   The impact of brain metastasis on quality of life, resource utilization and survival in patients with non-small-cell lung cancer [J].
Peters, Solange ;
Bexelius, Christin ;
Munk, Veronica ;
Leighl, Natasha .
CANCER TREATMENT REVIEWS, 2016, 45 :139-162